Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Tyrothricin Peptide Antibiotic Mixture: Applied Antimicrobia
2026-07-01
Tyrothricin offers bench scientists a robust, multi-pathogen tool for dissecting antimicrobial mechanisms and membrane disruption. This guide walks through optimized protocols, advanced applications, troubleshooting, and translates the latest insights on cellular regulation into actionable assay innovation.
-
Coumestrol in Rheumatoid Arthritis: Expanding SERM Research
2026-07-01
Explore how Coumestrol acts as a phytoestrogen estrogen receptor antagonist, uniquely inducing ferroptosis in RA synoviocytes. This article provides a deeper, protocol-oriented analysis of Coumestrol for SERM studies and practical assay design.
-
Tivozanib (AV-951): Optimizing VEGFR Inhibition in Cancer As
2026-06-30
Tivozanib (AV-951) delivers unparalleled selectivity and potency for VEGFR inhibition, driving precise anti-angiogenic and cell viability studies in oncology research. This guide provides actionable workflows, troubleshooting insights, and protocol enhancements grounded in quantitative evidence and recent methodological advances.
-
Oligomycin A: Precision Mitochondrial ATP Synthase Inhibitor
2026-06-30
Oligomycin A stands as the benchmark mitochondrial ATP synthase inhibitor, empowering researchers to dissect bioenergetic adaptations and apoptosis mechanisms in cancer and cell fate models. This guide delivers actionable protocols, troubleshooting strategies, and context from cutting-edge studies—enabling robust, reproducible results in advanced mitochondrial bioenergetics research.
-
FXR-KLF11 Axis: CDCA Suppresses JAK2/STAT3 in CI-AKI Models
2026-06-29
This study uncovers that Chenodeoxycholic Acid (CDCA) activates the FXR-KLF11 axis to suppress JAK2/STAT3 signaling, markedly reducing contrast-induced acute kidney injury (CI-AKI) in preclinical models. These findings clarify a nephroprotective mechanism with potential translational value for metabolic and kidney disease research.
-
Betacoronaviruses Modulate Host Stress Response for Replicat
2026-06-29
This study delineates how three human betacoronaviruses—SARS-CoV-2, MERS-CoV, and HCoV-OC43—differentially manipulate the integrated stress response (ISR) via eIF2α phosphorylation to optimize their replication in lung-derived cell lines. The findings clarify subtype-specific reliance on protein phosphorylation signaling pathways, revealing new opportunities for dissecting viral-host interactions in translational control.
-
Cyclo (-RGDfC): Optimizing Integrin-Mediated Tumor Targeting
2026-06-28
Cyclo (-RGDfC) enables high-fidelity integrin αvβ3 targeting for tumor biology, drug delivery, and angiogenesis research, outclassing linear analogs in stability and specificity. Learn how to maximize its performance using advanced photopatterning, robust protocols, and troubleshooting guidance inspired by the latest hydrogel platform innovations.
-
Optimizing mRNA Vaccine Synthesis: HyperScribe™ Kit Insights
2026-06-27
Explore how the HyperScribe All in One mRNA Synthesis Kit Plus 1 empowers advanced, immune-evasive mRNA vaccine development. This article reveals workflow-critical findings and practical guidance beyond conventional kit reviews.
-
LNP-Stabilized Emulsions Enable Precise mRNA Delivery to Boo
2026-06-26
Zhou et al. introduce a lipid nanoparticle-stabilized emulsion (LSE) system that achieves spatiotemporal control of mRNA delivery, favoring direct antigen presentation in antigen-presenting cells and eliciting robust, durable T cell responses in vivo. This innovation addresses key bottlenecks of conventional LNP platforms in mRNA vaccine and immunotherapy research.
-
Homoharringtonine: Cytotoxic Alkaloid Workflows in Cancer &
2026-06-26
Homoharringtonine empowers labs with dual-action precision: robust cell cycle arrest in leukemia models and nanomolar-range inhibition of SARS-CoV-2 replication. This guide delivers actionable protocols, troubleshooting strategies, and comparative insights to help scientists maximize data reproducibility and accelerate translational breakthroughs.
-
FAST Platform Enables Food-Grade Nutraceutical Nanoparticles
2026-06-25
The Cai et al. study demonstrates that Facilitated Self-Assembling Technology (FAST) enables rapid, food-grade production of stable nutraceutical nanoparticles without synthetic surfactants. This clean-label approach improves solubility, bioavailability, and regulatory compliance, with practical implications for the next generation of oral supplement delivery.
-
Spatially Patterned Kidney Assembloids for High-Fidelity Dis
2026-06-25
Huang et al. introduce spatially organized human kidney progenitor assembloids that more accurately recapitulate in vivo kidney development, cellular complexity, and physiological function. This innovation significantly advances disease modeling and regenerative medicine, providing a robust platform for studying late-onset kidney diseases and complex cell-cell interactions.
-
Cyclosporin A: Deep Mechanistic Insights for T-Cell and Mito
2026-06-24
Explore the latest research on Cyclosporin A, a potent immunosuppressive cyclic undecapeptide, with new mechanistic and protocol guidance for T-cell and mitochondrial assays. Unique insights bridge foundational signaling with advanced experimental design.
-
HyperFluor™ 488 Goat Anti-Human IgG: Enabling Precision Immu
2026-06-23
Discover how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody advances immune profiling in translational research. This deep dive explores its scientific mechanism, unique advantages, and its critical role in high-sensitivity assays.
-
Caspase-3 Colorimetric Assay Kit: Protocol & QC for Apoptosi
2026-06-23
The Caspase-3 Colorimetric Assay Kit enables sensitive, quantitative detection of caspase-3 activity in cell lysates—a crucial step in apoptosis and neurodegeneration research. It is best suited for in vitro applications where DEVD-dependent caspase-3 activity is a biomarker. This kit is not designed for in vivo or single-cell analyses.